Literature DB >> 21647599

Migration and chemokine receptor pattern of colitis-preventing DX5+NKT cells.

Matthias Hornung1, Jens M Werner, Stefan Farkas, Hans J Schlitt, Edward K Geissler.   

Abstract

PURPOSE: DX5(+)NKT cells are a subpopulation of NKT cells expressing both T cell receptor and NK cell markers that show an immune-regulating function. Transferred DX5(+)NKT cells from immune competent Balb/c mice can prevent or reduce induced colitis in severe combined immunodeficient (SCID) mice. Here, we investigated the in vivo migration of DX5(+)NKT cells and their corresponding chemokine receptor patterns.
METHODS: DX5(+)NKT cells were isolated from spleens of Balb/c mice and transferred into Balb/c SCID mice. After 2 and 8 days, in vivo migration was examined using in vivo microscopy. In addition, the chemokine receptor pattern was analyzed with fluorescence-activated cell sorting (FACS) and the migration assay was performed.
RESULTS: Our results show that labeled DX5(+)NKT cells were primarily detectable in mesenteric lymph nodes and spleen after transfer. After 8 days, DX5(+)NKT cells were observed in the colonic tissues, especially the appendix. FACS analysis of chemokine receptors in DX5(+)NKT cells revealed expression of CCR3, CCR6, CCR9, CXCR3, CXCR4, and CXCR6, but no CCR5, CXCR5, or the lymphoid homing receptor CCR7. Stimulation upregulated especially CCR7 expression, and chemokine receptor patterns were different between splenic and liver DX5(+)NKT cells.
CONCLUSIONS: These data indicate that colitis-preventing DX5(+)NKT cells need to traffic through lymphoid organs to execute their immunological function at the site of inflammation. Furthermore, DX5(+)NKT cells express a specific chemokine receptor pattern with an upregulation of the lymphoid homing receptor CCR7 after activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21647599     DOI: 10.1007/s00384-011-1249-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  51 in total

Review 1.  NKT cells: what's in a name?

Authors:  Dale I Godfrey; H Robson MacDonald; Mitchell Kronenberg; Mark J Smyth; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

2.  Initiation of cellular organization in lymph nodes is regulated by non-B cell-derived signals and is not dependent on CXC chemokine ligand 13.

Authors:  Tom Cupedo; Frances E Lund; Vu N Ngo; Troy D Randall; Wendy Jansen; Mascha J Greuter; Rene de Waal-Malefyt; Georg Kraal; Jason G Cyster; Reina E Mebius
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

Review 3.  Chemokines and chemokine receptors: their manifold roles in homeostasis and disease.

Authors:  Yingying Le; Ye Zhou; Pablo Iribarren; Jiming Wang
Journal:  Cell Mol Immunol       Date:  2004-04       Impact factor: 11.530

4.  Immune suppression and skin cancer development: regulation by NKT cells.

Authors:  A M Moodycliffe; D Nghiem; G Clydesdale; S E Ullrich
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

Review 5.  CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity.

Authors:  K Benlagha; A Bendelac
Journal:  Semin Immunol       Date:  2000-12       Impact factor: 11.130

6.  DX5+ NKT cells induce the death of colitis-associated cells: involvement of programmed death ligand-1.

Authors:  Matthias Hornung; Stefan A Farkas; Christine Sattler; Hans J Schlitt; Edward K Geissler
Journal:  Eur J Immunol       Date:  2006-05       Impact factor: 5.532

7.  Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells.

Authors:  Fengshuo Lan; Defu Zeng; Masanori Higuchi; John P Higgins; Samuel Strober
Journal:  Biol Blood Marrow Transplant       Date:  2003-06       Impact factor: 5.742

8.  CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells.

Authors:  Seddon Y Thomas; Runhua Hou; Jonathan E Boyson; Terry K Means; Christoph Hess; Douglas P Olson; Jack L Strominger; Michael B Brenner; Jenny E Gumperz; S Brian Wilson; Andrew D Luster
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

9.  Chemokine requirements for B cell entry to lymph nodes and Peyer's patches.

Authors:  Takaharu Okada; Vu N Ngo; Eric H Ekland; Reinhold Förster; Martin Lipp; Dan R Littman; Jason G Cyster
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

10.  Tumor-infiltrating effector cells of alpha-galactosylceramide-induced antitumor immunity in metastatic liver tumor.

Authors:  Takuya Osada; Hirokazu Nagawa; Yoichi Shibata
Journal:  J Immune Based Ther Vaccines       Date:  2004-07-13
View more
  1 in total

1.  Effect of PD-1: PD-L1 in Invariant Natural Killer T-Cell Emigration and Chemotaxis Following Sepsis.

Authors:  John S Young; Daithi S Heffernan; Chun-Shiang Chung; Maude L Kettenmann; Whitney A Young; Valeria Sanabria Guillen; William G Cioffi; Alfred Ayala
Journal:  Shock       Date:  2016-05       Impact factor: 3.454

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.